title: Plasmapheresis to treat human T lymphotropic virus type I-associated myelopathy.
authors: First Department of Internal Medicine, Nagasaki University School of Medicine, Japan.
authors: H
authors: H
authors: Matsuo
authors: T
authors: T
authors: Nakamura
authors: K
authors: K
authors: Shibayama
authors: M
authors: M
authors: Motomura
authors: K
authors: K
authors: Nagasato
authors: G
authors: G
authors: Takeo
authors: M
authors: M
authors: Tsujihata
authors: S
authors: S
authors: Nagataki
mesh_terms: D000328:Adult; D000368:Aged; D003131:Combined Modality Therapy; D003520:Cyclophosphamide / Q000627:therapeutic use; D005069:Evaluation Studies as Topic; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007370:Interferon Type I / Q000627:therapeutic use; D007937:Leukapheresis; D008297:Male; D008875:Middle Aged; D015493:Paraparesis, Tropical Spastic / Q000188:drug therapy / Q000628:therapy*; D010956:Plasmapheresis; D011239:Prednisolone / Q000627:therapeutic use
chemical_list: D007370:Interferon Type I; D003520:Cyclophosphamide; D011239:Prednisolone